Efficacy and Safety of Morning Versus Evening Dose of Controlled-Release Simvastatin Tablets in Patients With Hyperlipidemia: A Randomized, Double-Blind, Multicenter Phase III Trial

Sang-Hyun Kim; Min-Kyung Kim; Hong-Seok Seo; Min-Soo Hyun; Kyoo-Rok Han; Seong-Wook Cho; Young-Kwon Kim; Seong Hoon Park

doi:10.1016/j.clinthera.2013.06.020

Efficacy and Safety of Morning Versus Evening Dose of Controlled-Release Simvastatin Tablets in Patients With Hyperlipidemia: A Randomized, Double-Blind, Multicenter Phase III Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2013.06.020 ◽

2013 ◽

Vol 35 (9) ◽

pp. 1350-1360.e1 ◽

Cited By ~ 15

Author(s):

Sang-Hyun Kim ◽

Min-Kyung Kim ◽

Hong-Seok Seo ◽

Min-Soo Hyun ◽

Kyoo-Rok Han ◽

...

Keyword(s):

Controlled Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Evening Dose ◽

Phase Iii Trial ◽

Multicenter Phase

Download Full-text

A randomized, double-blind, placebo (P) controlled, multicenter phase III trial to evaluate the efficacy and safety of adding bevacizumab (B) to erlotinib (E) and gemcitabine (G) in patients (pts) with metastatic pancreatic cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4507 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4507-4507 ◽

Cited By ~ 23

Author(s):

W. Vervenne ◽

J. Bennouna ◽

Y. Humblet ◽

S. Gill ◽

M. J. Moore ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Iii ◽

Metastatic Pancreatic Cancer ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Multicenter Phase

Download Full-text

Custodiol-N versus custodiol: A prospective randomized double blind multicenter phase III trial

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-0034-1367380 ◽

2014 ◽

Vol 62 (S 01) ◽

Author(s):

G. Szabó ◽

A. Weymann ◽

B. Schmack ◽

D. Badowsky-Zyla ◽

G. Veres ◽

...

Keyword(s):

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Multicenter Phase

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1146988.604098 ◽

2009 ◽

Author(s):

Frank Pessler

Keyword(s):

Juvenile Idiopathic Arthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Withdrawal Phase ◽

Systemic Onset

Download Full-text

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

Arthritis & Rheumatism ◽

10.1002/art.22025 ◽

2006 ◽

Vol 54 (9) ◽

pp. 2793-2806 ◽

Cited By ~ 1041

Author(s):

Stanley B. Cohen ◽

Paul Emery ◽

Maria W. Greenwald ◽

Maxime Dougados ◽

Richard A. Furie ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis ◽

Phase Iii ◽

Primary Efficacy ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Factor Therapy ◽

Necrosis Factor

Download Full-text

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase

Download Full-text

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Parallel Group

Download Full-text

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase-4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24-week multicentre, randomized, double-blind, placebo-controlled phase III trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12631 ◽

2016 ◽

Vol 18 (5) ◽

pp. 528-532 ◽

Cited By ~ 12

Author(s):

S. Hong ◽

C.-Y. Park ◽

K. A. Han ◽

C. H. Chung ◽

B. J. Ku ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Download Full-text

A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis

Clinics in Orthopedic Surgery ◽

10.4055/cios.2017.9.4.439 ◽

2017 ◽

Vol 9 (4) ◽

pp. 439 ◽

Cited By ~ 3

Author(s):

Myungchul Lee ◽

Juhyung Yoo ◽

Jin Goo Kim ◽

Hee-Soo Kyung ◽

Seong-Il Bin ◽

...

Keyword(s):

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Trial ◽

Multicenter Phase

Download Full-text

Rationale and design of DECISION: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyroid cancer

BMC Cancer ◽

10.1186/1471-2407-11-349 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 60

Author(s):

Marcia S Brose ◽

Christopher M Nutting ◽

Steven I Sherman ◽

Young Kee Shong ◽

Johannes WA Smit ◽

...

Keyword(s):

Thyroid Cancer ◽

Differentiated Thyroid Cancer ◽

Radioactive Iodine ◽

Locally Advanced ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Trial

Download Full-text